Human cells are composed of lipid bilayers as their primary structure. HighField is addressing the immune response to complex disease through this role of lipids in the body. 

Lipids self-assemble into fascinating structures, and we design these structures to target different cells in complex disease biology. 

Our primary approach is to modify existing immune system cells as well as attack diseased tissue directly, all within the tumor microenvironment.  Our unique lipid structures allow for better patient outcomes using less toxic materials in a more economically viable system than current immunotherapies.